Evidence map›Paper›PMID 33466708›Full record

ArticleMicroorganisms2021

Anti-Pathogenic and Immune-Modulatory Effects of Peroral Treatment with Cardamom Essential Oil in Acute Murine Campylobacteriosis.

Markus M Heimesaat, Soraya Mousavi, Dennis Weschka, Stefan Bereswill

Open access · goldAbstract read
In one paragraph

Article in Microorganisms, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 26 citations in OpenAlex.

  1. Therapeutic and protective approaches to combatFrontiers in pharmacology · 2025
    Review
  2. Principles and Therapeutics ofJournal of pharmacy & bioallied sciences · 2024
    Review
  3. Article
  4. Antilisterial Effectiveness ofFoods (Basel, Switzerland) · 2024
    Article
  5. Article
  6. Review
  7. Molecular Targets inBiomolecules · 2023
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Treatment with the Probiotic Product AviguardInternational journal of molecular sciences · 2021
    Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Markus M HeimesaatGastrointestinal Microbiology Research Group, Institute of Microbiology, Infectious Diseases and Immunology, Charité-University Medicine Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, 12203 Berlin, Germany.ORCID 0000-0001-6399-651X
Soraya MousaviGastrointestinal Microbiology Research Group, Institute of Microbiology, Infectious Diseases and Immunology, Charité-University Medicine Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, 12203 Berlin, Germany.
Dennis WeschkaGastrointestinal Microbiology Research Group, Institute of Microbiology, Infectious Diseases and Immunology, Charité-University Medicine Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, 12203 Berlin, Germany.
Stefan BereswillGastrointestinal Microbiology Research Group, Institute of Microbiology, Infectious Diseases and Immunology, Charité-University Medicine Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, 12203 Berlin, Germany.
Humboldt-Universität zu Berlin · DE

Funding

Bundesministerium für Bildung und Forschung IP7 / 01KI1725D, PAC-CampyBundesministerium für Wirtschaft und Energie ZF4117908 AJ8, ZIM
6 · The paper itself

Abstract

Human infections with enteropathogenic

Indexed as

antipathogenic effectscampylobacteriosis modelCampylobacter jejunicardamom essential oilenteropathogenic infectionhost–pathogen interactionimmune-modulatory effectsmicrobiota-depleted IL-10−/− micepreclinical intervention study

Identifiers

PMID33466708
PMCPMC7828794
OpenAlexW3120252130

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.